Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,975.00
Bid: 1,975.00
Ask: 1,977.00
Change: -9.00 (-0.45%)
Spread: 2.00 (0.101%)
Open: 1,988.00
High: 1,990.00
Low: 1,975.00
Prev. Close: 1,984.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 17th Mar 2014 08:31

Admiral Group: Credit Suisse raises target price from 1340p to 1425p and keeps a neutral rating.African Barrick Gold: Canaccord Genuity ups target price from 315p to 330p and maintains a buy recommendation.Amara Mining: Canaccord Genuity moves target price from 25p to 33p and reiterates its buy recommendation.Avocet Mining: Canaccord Genuity shifts target price from 6p to 8p, but still recommends selling.Balfour Beatty: UBS moves target price from 250p to 260p, but still recommends selling.Barratt Developments: Deutsche Bank shifts target price from 452p to 453p keeping a buy recommendation.Bodycote: JP Morgan raises target price from 540p to 655p, while leaving its underweight rating unaltered.Burberry: Nomura ups target price from 1630p to 1650p and maintains a neutral rating.bwin.party: Citi cuts target price from 125p to 95p and downgrades from neutral to sell.Centamin: Canaccord Genuity moves target price from 53p to 68p and retains its speculative buy recommendation.Computacenter: Jefferies raises target price from 470p to 720p and retains a hold recommendation. Barclays initiates with a target price of 600p and an underweight rating.Gulf Keystone: Westhouse Securities cuts target price from 160p to 125p and maintains a neutral rating.Hellenic Carriers: Panmure Gordon moves target price from 50p to 60p and keeps a buy recommendation.Hikma Pharmaceuticals: Citi raises target price from 1700p to 1800p and reiterates a buy recommendation.Innovation Group: Investec shifts target price from 42p to 45p and keeps a buy recommendation.International Personal Finance: RBC Capital cuts target price from 595p to 575p and maintains an outperform rating.Micro Focus: Barclays upgrades to overweight with a target price of 900p.Minera IRL: Canaccord Genuity shifts target price from 19p to 20p and maintains its speculative buy recommendation.Moneysupermarket: Westhouse Securities shifts target price from 220p to 223p, while downgrading from buy to add.Morrison (Wm): Deutsche Bank upgrades to hold with a target price of 200p.Next: Jefferies raises target price from 7000p to 7500p and keeps a buy recommendation.Oxford Instruments: UBS reduces target price from 1750p to 1600p, while leaving its buy recommendation unaltered.Pan Africa Resources: Canaccord Genuity shifts target price from 16p to 18p and retains a buy recommendation.Petropavlovsk: Canaccord Genuity takes target price from 71p to 106p upgrading to buy. Polymetal International: Canaccord Genuity raises target price from 510p to 670p upgrading to buy.Provident Financial: RBC Capital increases target price from 1650p to 1875p maintaining a neutral rating.Randgold Resources: Canaccord Genuity raises target price from 3800p to 4800p and maintains a hold recommendation.Reed Elsevier: Berenberg takes target price from 895p to 930p, but downgrades from buy to hold.Regus: JP Morgan lowers target price from 177p to 174p and retains an underweight rating.Royal Dutch Shell: Credit Suisse raises target price from 2350p to 2450p and maintains an outperform rating.RPS Group: JP Morgan moves target price from 341p to 351p and reiterates an overweight rating.Salamander Energy: Deutsche Bank moves target price from 175p to 185p and retains a buy recommendation. Barclays cuts target price from 160p to 130p and keeps an equal-weight rating.Schroders: RBC Capital raises target price from 2550p to 2800p and stays with its neutral rating.Telit Communications: Canaccord Genuity ups target price from 230p to 245p staying with its buy recommendation.Tracsis: WH Ireland ups target price from 244p to 273p leaving its buy recommendation unchanged.Wolseley: Citi increases target price from 3596p to 3660p and maintains a buy recommendation.WPP Group: Liberum Capital reduces target price from 1600p to 1280p, while its hold recommendation remains unchanged.
More News
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more
27 Aug 2021 12:32

Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody

(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.

Read more
20 Aug 2021 09:46

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

Read more
20 Aug 2021 08:10

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Read more
17 Aug 2021 09:46

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...

Read more
12 Aug 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Aug 2021 17:06

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.